← Teladoc Health, Inc.
| Annual Trend | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $123.2m |
$233.3m
+89.42%
|
$417.9m
+79.14%
|
$553.3m
+32.40%
|
$1.1b
+97.71%
|
$2.0b
+85.81%
|
$2.4b
+18.41%
|
$2.6b
+8.13%
|
$2.6b
-1.26%
|
$2.5b
-1.54%
|
$2.5b
-1.60%
|
|
| Cost of Revenue | $32.0m |
$61.6m
+92.75%
|
$128.7m
+108.91%
|
$184.5m
+43.29%
|
$390.8m
+111.87%
|
$650.3m
+66.38%
|
$744.0m
+14.41%
|
$760.0m
+2.16%
|
$751.3m
-1.15%
|
$771.6m
+2.71%
|
$772.6m
+0.13%
|
|
| Cost of Goods and Service, Excluding Depreciation, Depletion, and Amortization | $32.0m |
$61.6m
+92.75%
|
$128.7m
+108.91%
|
$184.5m
+43.29%
|
$390.8m
+111.87%
|
$650.3m
+66.38%
|
$744.0m
+14.41%
|
$760.0m
+2.16%
|
$751.3m
-1.15%
|
$771.6m
+2.71%
|
$772.6m
+0.13%
|
|
| Gross Profit | $91.2m |
$171.7m
+88.25%
|
$289.2m
+68.46%
|
$368.8m
+27.55%
|
$703.1m
+90.63%
|
$1.4b
+96.61%
|
$1.7b
+20.28%
|
$1.8b
+10.80%
|
$1.8b
-1.31%
|
$1.8b
-3.30%
|
$1.7b
-2.36%
|
|
| Interest Income (Expense), Net | ($2.6m) |
($17.5m)
-575.85%
|
($26.1m)
-49.29%
|
($29.0m)
-11.11%
|
($60.5m)
-108.51%
|
($80.4m)
-32.85%
|
($9.3m)
+88.47%
|
— | — | — | $27.0m | |
| Research and Development Expense | $21.8m | $34.5m | $54.4m | $64.6m | $164.9m | $311.9m | $333.6m | $348.5m | $307.3m | $277.9m | $269.9m | |
| Marketing and Advertising Expense | $34.7m | $57.7m | $85.1m | $109.7m | $226.1m | $416.7m | $623.5m | $688.9m | $705.8m | $653.4m | — | |
| General and Administrative Expense | $48.6m | $79.8m | $116.9m | $157.7m | $497.8m | $438.0m | $449.9m | $464.7m | $435.5m | $431.9m | $417.1m | |
| Amortization of Intangible Assets | $6.1m | $15.3m | $31.5m | $35.6m | $64.7m | $195.3m | $244.6m | $325.9m | $363.4m | $350.8m | — | |
| Restructuring Costs | — | — | — | — | $0 | $0 | $7.4m | $16.9m | $20.4m | $18.8m | — | |
| Operating expenses: | ||||||||||||
| Operating Income (Loss) | ($62.7m) |
($75.4m)
-20.31%
|
($70.9m)
+6.02%
|
($80.4m)
-13.53%
|
($506.4m)
-529.55%
|
($265.6m)
+47.55%
|
($13.7b)
-5039.92%
|
($248.6m)
+98.18%
|
($1.0b)
-310.73%
|
($263.0m)
+74.24%
|
($145.7m)
+44.61%
|
|
| Foreign Currency Transaction Gain (Loss), Realized | — | ($100k) | $100k | $200k | ($600k) | — | — | — | — | — | — | |
| Other Nonoperating Income (Expense) | — | — | — | — | — | $5.1m | ($859k) | $4.4m | ($6.0m) | $10.4m | — | |
| Interest Expense (non-operating) | — | — | — | — | — | $81.1m | $21.9m | $22.3m | $23.8m | $19.7m | $20.0m | |
| Income (Loss) from Continuing Operations before Income Taxes, Domestic | $73.7m | ($107.7m) | ($91.1m) | ($95.5m) | ($566.3m) | ($365.8m) | ($13.3b) | ($192.7m) | ($990.0m) | ($232.3m) | ($182.6m) | |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | ($73.7m) | ($107.0m) | ($97.0m) | ($109.5m) | ($576.0m) | ($384.7m) | ($13.7b) | ($219.6m) | ($993.7m) | ($235.5m) | ($182.6m) | |
| Current Income Tax Expense (Benefit) | — | $366k | $2.0m | $277k | ($322k) | $3.2m | $4.0m | $2.7m | $8.7m | $6.2m | ($5.2m) | |
| Income Tax Expense (Benefit) | $510k | ($225k) | $118k | ($10.6m) | ($90.9m) | $44.1m | ($3.8m) | $760k | $7.6m | ($35.2m) | ($5.2m) | |
| Net Income (Loss) Attributable to Parent | ($74.2m) |
($106.8m)
-43.88%
|
($97.1m)
+9.08%
|
($98.9m)
-1.83%
|
($485.1m)
-390.71%
|
($428.8m)
+11.61%
|
($13.7b)
-3085.58%
|
($220.4m)
+98.39%
|
($1.0b)
-354.35%
|
($200.3m)
+79.99%
|
($177.4m)
+11.45%
|
|
| Earnings Per Share, Basic | — | — | — | ($1.38) | ($5.36) | ($2.73) | ($84.60) | ($1.34) | ($5.87) | ($1.14) | ($0.99) | |
| Earnings Per Share, Diluted | — | — | — | ($1.38) | ($5.36) | ($2.73) | ($84.60) | ($1.34) | ($5.87) | ($1.14) | ($0.99) | |
| Weighted Average Number of Shares Outstanding, Basic | — | — | — | — | — | 156.9m | 161.5m | 164.6m | 170.6m | 176.2m | 178.7m | |
| Weighted Average Number of Shares Outstanding, Diluted | — | — | — | — | — | 156.9m | 161.5m | 164.6m | 170.6m | 176.2m | 178.7m | |
| Additional Financial Items | ||||||||||||
| Business Combination, Acquisition Related Costs | $7.0m | $13.2m | $10.4m | $6.6m | $88.2m | $26.6m | $15.6m | $21.1m | $1.7m | $9.0m | — | |
| Capitalized Computer Software, Amortization | — | — | — | — | — | — | $46.1m | $83.0m | $133.0m | $167.6m | — | |
| Costs and Expenses | — | — | — | $633.7m | $1.6b | $2.3b | $16.1b | $2.9b | $3.6b | $2.8b | — | |
| Goodwill, Impairment Loss | $0 | $0 | $0 | $0 | $0 | — | $13.4b | $0 | $790.0m | $71.8m | $12.6m | |
| Realized Investment Gains (Losses) | — | — | — | — | — | $5.9m | $0 | $0 | — | — | — | |
| Selling Expense | $26.2m | $38.0m | $59.2m | $64.9m | $154.1m | $250.6m | $227.2m | $213.8m | $205.0m | $194.5m | — | |
| Share-based Payment Arrangement, Expensed and Capitalized, Amount | — | — | — | — | — | — | — | $221.0m | $158.7m | $88.0m | — |
Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.